Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways
about
Unraveling insulin-like growth factor binding protein-3 actions in human diseaseTargeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast CancerNuclear actions of insulin-like growth factor binding protein-3Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activityEGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-IAmyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's diseaseInsulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthmaProtection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional eventsTNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cellsPericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors.Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium.IGFBP-3 may trigger osteoarthritis by inducing apoptosis of chondrocytes through Nur77 translocationIGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levelsPotent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2.Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function.Histone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradationInsulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro.Targeting angiogenesis in childhood sarcomas.Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells.miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3.Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide.Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage.Differential stage-dependent regulation of prostatic epithelial morphogenesis by Hedgehog signaling.Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.Tear Levels of Insulin-Like Growth Factor Binding Protein 3 Correlate With Subbasal Nerve Plexus Changes in Patients With Type 2 Diabetes Mellitus.Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft tissue sarcoma growth depend on tumor developmental stage.Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.Biologically active constituents of the secretome of human W8B2+ cardiac stem cells.ISL1 overexpression enhances the survival of transplanted human mesenchymal stem cells in a murine myocardial infarction model.
P2860
Q24650060-F639211D-DAEC-4EAA-9E71-F749A480EF94Q26801886-8B9DDA6C-D643-44A7-BB33-7679462C9B34Q28080513-1D1258DB-63A1-4AC5-B152-8F9D0559FC08Q28253045-82D8F96D-E12E-4BD5-BC54-A87DF6F5A1DEQ28275900-1AA582D3-11CD-4060-A217-D594D8BF2F91Q31168146-01C0A29A-69C3-4B3A-ABC2-F3B949327063Q33504506-5BF5FF80-187C-4A1C-8379-8FDA5A76233FQ33756365-31B97D20-80CD-4DA3-B001-C73253585E39Q34335696-5884245C-7A53-44A6-B414-1D9FE6CD6C07Q34484983-EC0A57D5-4C47-4A6E-AD86-4901826DBF00Q34805398-2B6DD244-740D-49BB-B221-5140773A374AQ35001398-80B6B065-5043-4E50-B414-A7C25EA59471Q35197405-EFCA8951-C366-4DA5-AC14-4793BFDB2CC6Q35215117-888C49AC-66BE-4DDA-AE92-27E9B335ED7DQ35724475-A745B397-643A-4F87-B96C-BD977C843B41Q35860085-586CB4FC-472F-4498-980E-769A99815CD5Q35878260-F6B5E88B-EB25-42A1-90AB-DE24BEA8DF56Q35925681-FCAA473A-B616-43C9-8B7E-B844D596AE20Q35973404-B2E3ACBC-627E-4A7F-9F75-1DB5F4EF5F60Q35973411-10C43514-C70C-44AE-8CAA-D135DEEA766AQ36041947-CB12F892-827D-47ED-BE0B-E012BEC48791Q36170917-67E324D7-41C9-4ACA-9902-9EA94786CF57Q36413546-7294730A-CE91-4C50-888F-9DED17DD4E11Q36415172-AAC008BC-6A77-47FA-A523-5CE4887A808EQ36767863-C3CAD989-32E3-4B24-804F-44C5BD2023C2Q37004744-971DBAE4-F748-45C1-A42C-F881220DABF9Q37137690-A6C23F4A-CB94-44A5-A3BA-BEEB81AD74B6Q37428196-172C7570-2354-4620-80E7-7376785A3EBCQ37825441-58CC0CC4-513C-4424-8D48-8FAEAA00A7ABQ38675999-800F7028-EC42-4A57-9715-AA88BE71B952Q41047924-7182B067-CBCD-4C36-B47A-AF72F8C79996Q42175059-2BEAE3AF-CBFD-43B0-AB15-A407C46F7720Q42600588-FD67AAF5-1AC6-480B-987B-8AF9125B0EDDQ43103034-901AAC28-7DFF-4475-BBD5-C892C4AF06C1Q45282577-9B13E3A7-308D-40BE-A50C-E438218D8966Q47126246-8A90CEA4-7045-4CD8-8400-D35680ED6FEBQ47340171-71B6178B-F2A0-46A6-B21D-DE4A17388824Q47435335-BF20B385-A15F-485D-86B4-CCBFD152EA3EQ48162551-7446001E-2589-4E19-BF07-D286FD6258CFQ50338644-2954A036-1E69-45AA-8C21-66AB527B867D
P2860
Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@ast
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@en
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@nl
type
label
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@ast
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@en
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@nl
prefLabel
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@ast
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@en
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@nl
P2093
P356
P1433
P1476
Dual effects of IGFBP-3 on end ...... phingolipid signaling pathways
@en
P2093
Ezio Ghigo
Giovanni Garbarino
Giusy Sala
Letizia Trovato
Marina Taliano
Renata Ponti
P304
P356
10.1096/FJ.04-1618FJE
P407
P577
2004-09-01T00:00:00Z